Abstract
Case report:
Our patient was 55 years old woman, who came to our clinic due to impair
ed
visual
acuity and the cataract of both eyes was diagnosed. The cataract surgery was performed on both eyes
with trifocal IOL implantation in November and December 2019 and postoper
ative process was
uncomplicated. 2 months later, the patient came because of impaired visual acuity in both eyes. The
bilateral postoperative CMO was diagnosed by using OCT imaging and topic NSAIDs and Aescin
was recommended. With conservative therapy, the
oedema was reduced
,
and visual acuity improved
which is still stable.
Discussion:
Cystoid macular oedema after cataract surgery (pseudofakic CMO) is defined as a
transient thickening of the macula after cataract surgery. The incidence of PCMO with
contemporary
surgical techniques of phacoemulsification surgery
decreases significantly, during uncomplicated
phacoemulsification the incidence has been reported between 4
-
11 %,
the incidence of clinical PCMO
has been reported at lower rates between
0.1
-
2.
3 %. CMO can also be a complication of various eye
diseases
–
eg. diabetic retinopathy, retinal vein occlusion or intraocular inflammation. The general
symptoms of PCMO are blurred vision, loss of contrast sensitivity and metamorphopsia.
The
diagnosis is d
etermineted by the
slit‐lamp biomicroscopy
, Amsler chart, OCT imaging and FAG. In
the treatment of PCMO we could use topical or systemic NSAID, Aescin, carbonic anhydrase
inhibitors, anti
-
VEGF agents or corticosteroids.
CMO is still somehow understimated and overlooked complication of cataract surgery. I routinely apply triamcinolon into the vitreous trans-zonularly at the end of all my cataract cases. This significantly lowers the risk of CMO.